Henry Journal of Hematology & Hemotherapy

Henry Publishing Group

About the Journal

Henry Journal of Hematology & Hemotherapy is an open access, peer-reviewed International journal dedicated to disseminating the scientific knowledge globally. The intend readers of the journal are hematologists, academicians, researchers and practitioners.

Journal of Hematology & Hemotherapy is a medium which gives a platform to researchers to help the eminent readers and showcase their talents. It is one of the best open access journals that aims to publish the most complete and reliable source of information on discoveries and current developments as Original Articles, Review Articles, Case Reports, Short Communications, etc. in the field and provides online access without any restrictions or subscriptions to researchers worldwide.

Hematology is the science or study of blood, blood-forming organs and blood diseases and Hemotherapy is the treatment of disease by the use of blood or blood derivatives, as in transfusion.

Subject Area Include:

Thalassemia, Sickle Cell Disease, Hemolytic Anemia, Rh incompatibility, Myelodysplastic Syndrome, Aplastic Anemia, Spherocytosis, Allo-immunization, embolism, and Von Willebrand's disease, B-cell Lymphoma, Multiple myeloma, Bone Marrow Disease, Hemoglobinopathies, Haematocrit, Mycoplasma pneumonia, SplenectomyHaematological Disease, Aplastic anemia, Papillomatosis, Teat, Auto-hemotherapy, Blood transfusion, Plasmapheresis etc.

Authors may submit the manuscripts through the journal's online submission or as an e-mail attachment to hematology@henrypublishers.com

  • Antibiotics
  • Applied Biotechnology
  • Biocatalysis
  • Bioinformatics
  • Biotechnology Applications
  • Blue Biotechnology
  • Cardiovascular Biomaterials
  • Enzymes
  • Functional Genomics
  • Gene Expression
  • Gene Therapy
  • Genetic Manipulation
  • Green Biotechnology
  • Modern Biotechnology
  • Nano Biotechnology
  • Pesticides
  • Proteomics
  • Red Biotechnology
  • Structural Genomics
  • Transgenic Plants
  • White Biotechnology

Latest Articles

Assessment of Severity of Anaemia using Immunovirological and Erythropoietin Level among HIV Infected Patients

ESAN Ayodele J*, OSIME E. O, OGUNBUSUYI Bolu Esther, OYEDELE Titilayo E and OYEGUE Kelvin

Anaemia decreases survival, independently accelerates disease progression, and increases mortality among HIV-infected individuals. The association between anaemia and decreased survival has been found to be independent ...

IRAK4 Modulators for Treatment of Hematologic Malignancies

Mukherjee S, Ramachandra M and Samajdar S*

Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) plays an important role in Toll-Like Receptor (TLR) signalling and activation of innate immune responses. Impairment of the innate immunity is known to be associated with different inflammatory ...

Transfusion Transmitted Infections: Prevalence and Associated Factors, National Blood Transfusion and Research Center, Sana'a Capital, Yemen

Ghaleb YA*, Alshahari AZ, Ali MA, Al-Amad MA, and Al-Serouri AA

Transfusion-Transmissible Infectious (TTIs) agents such as Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV), syphilis and malaria are the greatest threats to blood safety for transfusion recipients ...

Cardiac recurrence in diffuse large B-cell lymphoma

Istemi Serin*, MedihaIrem Onar and Mehmet Hilmi Dogu

Non-Hodgkin Lymphoma (NHL) ranks first among all hematological malignancies. Diffuse Large B Cell Lymphoma (DLBCL) is a heterogeneous tumor group consisting of large and transformed B cells that make up 30-40% of all NHL. Unlike ...